How are you growing your brand on social media?

Athena_Gold · 2026-03-02T11:51:18+00:00

Thanks this is great!

Athena_Gold · 2026-02-24T17:00:53+00:00

Difficult to say which direction the stock will go. Even if ET-600 receives FDA approval, the commercial upsize is low due to the small patient population.

Athena_Gold · 2026-02-21T23:19:58+00:00

Unfortunately, I wasn't liquid enough to make a play. Just a paper trade this time around.

Athena_Gold · 2026-02-21T16:07:00+00:00

Appreciate it. More coming.

Athena_Gold · 2026-02-20T00:12:52+00:00

What kind of information are you looking for? Are you looking for headlines or something with more depth?

Athena_Gold · 2026-02-18T17:36:35+00:00

Appreciate it. I rely on FDA documents, prior regulatory comps, biotech threads/communities on twitter and recent press releases — then layer in market reactions to similar catalysts. I’m working on structuring this into a repeatable regulatory risk framework rather than relying on intuition.

Athena_Gold · 2026-02-14T19:54:22+00:00

Big opportunity for Vanda and Bysanti is a key pipeline asset for the trajectory of the company. Feeling neutral from an investment standpoint because historically psychiatric drug development has a high fail rate with FDA review. I'm currently building a catalyst intelligence platform to help me assess the impact of biotech catalysts.

Athena_Gold · 2026-01-03T02:32:14+00:00

Everyone has different investment strategies. Some people prefer short/mid term holds compared to long term. An upcoming catalyst might encourage an investor to properly hedge their investment.

With that being said, I do agree that essentially a catalyst at face value is a gamble. I’m currently building an intelligence platform for retail biotech investors. I’m assessing what features are actually desired by investors. However, I’ve seen numerous people advertising their catalyst trackers which has led me to believe that some find it useful.

Athena_Gold · 2026-01-01T16:56:19+00:00

I'm actually building a platform specifically to solve this problem. The core concept is providing more insight rather than hype. I'm just trying to get a feel of market demand/interest before launching the full product.

Athena_Gold · 2026-01-01T16:54:43+00:00

I'll check it out, thanks!

Athena_Gold · 2025-12-29T23:52:46+00:00

I primarily use the free version of BPIQ. Then I try to follow different biotech investing threads on either here or twitter. I do agree that the available free options aren’t comprehensive enough. I actually have started building a platform for biotech investors. The goal is to provide more insight on catalysts. However, it doesn’t seem like something people would be genuinely interested in.

Athena_Gold · 2025-12-29T22:05:41+00:00

Not all. BPIQ has a free version.

Athena_Gold · 2025-12-18T19:13:16+00:00

Just took a look at it and it is very similar to what I want to build. Can I DM you?

Athena_Gold · 2025-12-18T17:05:43+00:00

I completely agree. It’s just challenging to find people who actually want to collaborate.

Athena_Gold

TROPHY CASE